DEALS: OSI acquires Eyetech

DEALS

WHO

WITH

WHAT

SCOOP

OSI Pharmaceuticals

Eyetech Pharmaceuticals

$935M acquisition

OSI will gain Macugen, a drug developed for the wet version of macular degeneration.

Cardiome Pharma

Artesian Therapeutics

Acquisition with up to $32M in milestone payments

Cardiome will gain two advanced small molecule discovery programs in congestive heart failure.

Biovitrum

Arexis

Acquisition

Arexis is entering the clinic with experimental drugs for diabetes.